Patrick Yang
Co-Founder & General Partner @ Amity Ventures
San Francisco, United States
Patrick Yang is a Series A investor at Amity Ventures in San Francisco focused on Software and Artificial Intelligence. Patrick Yang, General Partner at Amity Ventures, has led the firm’s investments in CaptivateIQ, Evisort, Flick, MoQuality, TruePill, and Vowel. He sits on the boards of Evisort and MoQuality. His primary areas of investment focus include AI, consumer, logistics, mobility, and software. Patrick co-founded Amity Ventures with CJ Reim in 2017 afterthe two worked together at Highland Capital Partners.Prior to Amity, Patrick was a Vice President at Highland, where he sourced the firm’s investment in nuTonomy, an autonomous vehicle startup acquired by Delphi one year later for $450M. Patrick is from the Bay Area and holds a B.S. in Business Administration with a concentration in Engineering Leadership from University of California, Berkeley.Pat currently serves on the board of Advancing Women in Product, a non-profit that empowers women to enter and succeed in product management roles. In his free time, he enjoys hiking and eating in the San Francisco area, and attending sporting events—especially Warriors, 49ers, and Giants games.
- Total investments:
- 33
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries Patrick Yang invests in
Stages Patrick Yang invests in
Countries Patrick Yang invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Seed
- $2.5M–$5.6M
- Series A
- $5M–$16M
- Series B
- $35M–$50M
Investment Focus
Industry
- Software 8 (24%)
- Artificial Intelligence 6 (18%)
- Health Care 5 (15%)
- E-Commerce 4 (12%)
- SaaS 3 (9%)
Stage
- Series A 11 (33%)
- Seed 10 (30%)
- Series B 3 (9%)
- Series C 2 (6%)
- Pre-Seed 1 (3%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Sutra makes it easy for fitness instructors to build an online business. They can host live classes, sell on-demand video and workout content, and build memberships all on their own website. | $15M / Series A / Jun 06, 2025 | ||
| Sully is deploying autonomous medical workers into healthcare organizations to address the most expensive line item in healthcare: payroll ($800b/yr in the US alone). Today, Sully's autonomous workers can perform most medical staff tasks 100x faster and 20x cheaper. From Digital Triage Nurses and Autonomous Medical Assistants to DigitalScribes and Digital Receptionists, our workers can automate patient check-in, assessments, documentation, diagnosis support, and billing that integrates with Electronic Health Records (EHRs) | Series A / Feb 10, 2025 | ||
| Sully is deploying autonomous medical workers into healthcare organizations to address the most expensive line item in healthcare: payroll ($800b/yr in the US alone). Today, Sully's autonomous workers can perform most medical staff tasks 100x faster and 20x cheaper. From Digital Triage Nurses and Autonomous Medical Assistants to DigitalScribes and Digital Receptionists, our workers can automate patient check-in, assessments, documentation, diagnosis support, and billing that integrates with Electronic Health Records (EHRs) | Seed / Jan 24, 2025 | ||
| Sully is deploying autonomous medical workers into healthcare organizations to address the most expensive line item in healthcare: payroll ($800b/yr in the US alone). Today, Sully's autonomous workers can perform most medical staff tasks 100x faster and 20x cheaper. From Digital Triage Nurses and Autonomous Medical Assistants to DigitalScribes and Digital Receptionists, our workers can automate patient check-in, assessments, documentation, diagnosis support, and billing that integrates with Electronic Health Records (EHRs) | Seed / Apr 10, 2024 | ||
| Usage AI (usage.ai), a platform that empowers companies to reduce their monthly cloud expenditure. The company generates, on average, 35% in monthly AWS savings for its customers. Because the company has collected millions of data points from its opt-in users with a variety of usage patterns, it's been able to identify hard-to-find savingsthat humans can't detect. It takes less than 15 minutes for a company to onboard with the company. Additionally, the company's customers get the deep discounts of reservations with the flexibility of on-demand since companies can sell their reservations back to Usage AI after just 30 days. | $9M / Sep 12, 2023 | ||
| Controlrooms.ai develops a monitor system designed for industrial mission control rooms. It provides immediate time to benefit and exhibit intuitive functionality to help advance the quality of life on Earth, enabling companies by providing earth's monitoring services. The company was founded in 2021 and is based in Austin, Texas. | $10M / Series A / Aug 29, 2023 | ||
| Sutra makes it easy for fitness instructors to build an online business. They can host live classes, sell on-demand video and workout content, and build memberships all on their own website. | $7.6M / Series A / Dec 13, 2022 | ||
| Innerwell is a first-of-its-kind psychedelic teletherapy platform. They partnered with leaders in psychedelic therapy education, Fluence Training, to create a foundational course in ketamine-assisted psychotherapy that will equip you with the knowledge you need to practice confidently. | $3M / Pre-Seed / Jun 01, 2022 | ||
| Evisort is an AI-powered platform that revolutionizes contract lifecycle management with enterprise-grade AI that connects contract data across critical business systems. It is a commitment to secure, reliable, and ethical AI. Their platform empowers teams to manage and analyze contracts intelligently, transforming legal challenges into strategicopportunities. By adopting Evisort, one can elevate document management and set a new standard for AI adoption. | $100M / Series C / May 11, 2022 | ||
| Factored Quality is a quality control platform for e-commerce and consumer goods brands. Factored Quality specializes in the fields of freight service, logistics, and supply chain management. | $5.6M / Seed / Feb 15, 2022 | ||
| See all 33 investments → | |||
Co-Investors
About Amity Ventures
Amity Ventures is a people-focused firm that supports founders of technology companies in building category-defining businesses. Based in San Francisco, CA, the partners at Amity have invested in over fifty companies across all stages of company growth throughout their years in business together.
Amity Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
CJ Reim
Co-Founder & Managing Partner
|
|||
|
Patrick Yang
Co-Founder & General Partner
|
|||
Peter Bell
General Partner
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Patrick Yang invest in?
Patrick Yang invests primarily in Software, Artificial Intelligence and Health Care startups, most often at Series A and Seed stage. Most of the 33 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Patrick Yang's check size?
Patrick Yang typically joins rounds of $2.5M–$5.6M at Seed, $5M–$16M at Series A and $35M–$50M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Patrick Yang participates in.
How do I contact Patrick Yang?
Public channels for Patrick Yang include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Patrick Yang last invest?
The most recent investment recorded for Patrick Yang closed in Jun 2025. Shizune tracks 33 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
